Glucose or Intermittent High-Intensity Exercise in Glargine/Glulisine Users with T1DM

被引:26
作者
Dube, Marie-Christine [1 ]
Lavoie, Carole [2 ]
Weisnagel, S. John [1 ]
机构
[1] Univ Laval, Diabet Res Unit, Med Ctr, Quebec City, PQ, Canada
[2] Univ Quebec Trois Rivieres, Dept Phys Act Sci, Trois Rivieres, PQ, Canada
关键词
INTERMITTENT HIGH-INTENSITY EXERCISE; HYPOGLYCEMIA; STRATEGIES; TYPE; 1; DIABETES; INDUCED HYPOGLYCEMIA; DIABETIC-PATIENTS; BLOOD-GLUCOSE; INSULIN;
D O I
10.1249/MSS.0b013e31826c6ad3
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
DUBE, M.-C., C. LAVOIE, and S. J. WEISNAGEL. Glucose or Intermittent High-Intensity Exercise in Glargine/Glulisine Users with T1DM. Med. Sci. Sports Exerc., Vol. 45, No. 1, pp. 3-7, 2013. Introduction: The effects of glargine/glulisine insulin regimen on exercise blood glucose (BG) and strategies to limit exercise-induced hypoglycemia are not well documented. Intermittent high-intensity exercise has been proposed to prevent hypoglycemia, but its effect in participants with type 1 diabetes using glargine/glulisine is unknown. Methods: The study used a repeated-measures design with three randomly ordered exercise conditions. Eleven participants completed 60 min of moderate-intensity exercise at 50% (V) over dotO(2peak) for all conditions. These conditions varied as follows: participants ingested 0 g of glucose preexercise (0G + MOD), 30 g of glucose preexercise (30G + MOD), or 0 g of glucose preexercise but performed brief high-intensity intervals interspersed every 2 min (0G + MOD/INT) during exercise. If BG fell <4 mmol.L-1, a 20% dextrose solution was started to maintain BG between 4 and 5 mmol.L-1. Results: Consuming 30 g of glucose before exercise (30G + MOD) resulted in a higher preexercise BG (11.7 +/- 2.7 mmol.L-1) compared with 0 g of glucose before exercise (0G + MOD, 7.8 +/- 4.0, and 0G + MOD/INT, 9.2 +/- 3.5mmol.L-1), P < 0.05. A dextrose infusion was required in 7/11, 4/11, and 1/11 participants for 0G + MOD, 0G + MOD/INT, 30G + MOD conditions, respectively, P < 0.02. The duration and the quantity of dextrose infused were greatest in the 0G + MOD condition, moderate in the to 0G + MOD/INT condition, and minimal in the 30G + MOD condition, P < 0.01. Conclusion: Our results suggest that both moderate-intensity exercise with a 30-g preexercise glucose beverage or interspersed with intermittent high-intensity sprints may be safe strategies to prevent hypoglycemia in glargine/glulisine users.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 20 条
[11]  
Mollar-Puchades M A, 2009, Diabetes Res Clin Pract, V83, pe21, DOI 10.1016/j.diabres.2008.11.002
[12]   Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (Ultralente-Lispro) [J].
Rabasa-Lhoret, R ;
Bourque, J ;
Ducros, F ;
Chiasson, JL .
DIABETES CARE, 2001, 24 (04) :625-630
[13]  
RICHTERICH R, 1971, SCHWEIZ MED WSCHR, V101, P615
[14]  
Rossetti Paolo, 2008, Archives of Physiology and Biochemistry, V114, P3, DOI 10.1080/13813450801900777
[15]   GLYCEMIC CONTROL WITH PHYSICAL-TRAINING IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ROWLAND, TW ;
SWADBA, LA ;
BIGGS, DE ;
BURKE, EJ ;
REITER, EO .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (03) :307-310
[16]   THE EFFECT OF LONG-TERM INTENSIFIED INSULIN-TREATMENT ON THE DEVELOPMENT OF MICROVASCULAR COMPLICATIONS OF DIABETES-MELLITUS [J].
REICHARD, P ;
NILSSON, BY ;
ROSENQVIST, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) :304-309
[17]   Physical activity/exercise and type 2 diabetes - A consensus statement from the American diabetes association [J].
Sigal, Ronald J. ;
Kenny, Glen P. ;
Wasserman, David H. ;
Castaneda-Sceppa, Carmen ;
White, Russell D. .
DIABETES CARE, 2006, 29 (06) :1433-1438
[18]  
SILLS IN, 1983, MED SCI SPORT EXER, V15, P450
[19]  
TROVATI M, 1988, ANN MED INTERNE, V139, P149
[20]   EXERCISE-INDUCED HYPOGLYCEMIA IN IDDM PATIENTS TREATED WITH A SHORT-ACTING INSULIN ANALOG [J].
TUOMINEN, JA ;
KARONEN, SL ;
MELAMIES, L ;
BOLLI, G ;
KOIVISTO, VA .
DIABETOLOGIA, 1995, 38 (01) :106-111